A citation-based method for searching scientific literature

Lin-Rong Li, Liang Wang, Ying-Zhi He, Ken H Young. Expert Rev Hematol 2019
Times Cited: 4







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.
Adam M Petrich, Mitul Gandhi, Borko Jovanovic, Jorge J Castillo, Saurabh Rajguru, David T Yang, Khushboo A Shah, Jeremy D Whyman, Frederick Lansigan, Francisco J Hernandez-Ilizaliturri,[...]. Blood 2014
298
50

c-Myc modulates microRNA processing via the transcriptional regulation of Drosha.
Xingwu Wang, Xiaocheng Zhao, Ping Gao, Mian Wu. Sci Rep 2013
49
25

Mouse Models of c-myc Deregulation Driven by IgH Locus Enhancers as Models of B-Cell Lymphomagenesis.
Melissa Ferrad, Nour Ghazzaui, Hussein Issaoui, Jeanne Cook-Moreau, Yves Denizot. Front Immunol 2020
9
25

The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis.
Patrick A Carroll, Brian W Freie, Haritha Mathsyaraja, Robert N Eisenman. Front Med 2018
118
25


Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP.
Mamta Gupta, Matthew J Maurer, Linda E Wellik, Mark E Law, Jing Jing Han, Nazan Ozsan, Ivana N Micallef, Ahmet Dogan, Thomas E Witzig. Blood 2012
48
25

RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.
Tae Jin Lee, Ji Young Yoo, Dan Shu, Hui Li, Jianying Zhang, Jun-Ge Yu, Alena Cristina Jaime-Ramirez, Mario Acunzo, Giulia Romano, Ri Cui,[...]. Mol Ther 2017
79
25

MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma.
Jie Xu, Jing-Lan Liu, L Jeffrey Medeiros, Wenting Huang, Joseph D Khoury, Timothy J McDonnell, Guilin Tang, Ellen Schlette, C Cameron Yin, Carlos E Bueso-Ramos,[...]. Eur J Haematol 2020
10
25

MAD1 and its life as a MYC antagonist: an update.
Bernhard Lüscher. Eur J Cell Biol 2012
30
25

Targeting miR-21 with Sophocarpine Inhibits Tumor Progression and Reverses Epithelial-Mesenchymal Transition in Head and Neck Cancer.
Wei Liu, Beilei Zhang, Guo Chen, Wenjiao Wu, Lin Zhou, Yaru Shi, Qi Zeng, Yanqiu Li, Youwei Sun, Xingming Deng,[...]. Mol Ther 2017
35
25

Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.
James J Steinhardt, Raymond J Peroutka, Krystyna Mazan-Mamczarz, Qing Chen, Simone Houng, Carol Robles, Rolf N Barth, Joseph DuBose, Brandon Bruns, Ronald Tesoriero,[...]. Blood 2014
17
25

AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.
Zhendong Shi, Junxia Zhang, Xiaomin Qian, Lei Han, Kailiang Zhang, Luyue Chen, Jilong Liu, Yu Ren, Ming Yang, Anling Zhang,[...]. Cancer Res 2013
134
25

MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Heounjeong Go, Ji-Young Jang, Pil-Jong Kim, Young-Goo Kim, Soo Jeong Nam, Jin Ho Paik, Tae Min Kim, Dae Seog Heo, Chul-Woo Kim, Yoon Kyung Jeon. Oncotarget 2015
81
25

A mammalian functional-genetic approach to characterizing cancer therapeutics.
Hai Jiang, Justin R Pritchard, Richard T Williams, Douglas A Lauffenburger, Michael T Hemann. Nat Chem Biol 2011
68
25

A novel SAHA-bendamustine hybrid induces apoptosis of leukemia cells.
Jing Yu, Shaowei Qiu, Qiufu Ge, Ying Wang, Hui Wei, Dianwu Guo, Shuying Chen, Shuang Liu, Shouyun Li, Haiyan Xing,[...]. Oncotarget 2015
14
25

MYC alterations in diffuse large B-cell lymphomas.
Kennosuke Karube, Elias Campo. Semin Hematol 2015
61
25

A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency.
Chuan Liu, Hongyu Ding, Xiaoxi Li, Christian P Pallasch, Liya Hong, Dianwu Guo, Yi Chen, Difei Wang, Wei Wang, Yajie Wang,[...]. EMBO Mol Med 2015
17
25

High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects.
Xia Li, Chenying Li, Jingrui Jin, Jinghan Wang, Jiansong Huang, Zhixin Ma, Xin Huang, Xiao He, Yile Zhou, Yu Xu,[...]. EBioMedicine 2018
30
25

Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.
Ping Mu, Yoon-Chi Han, Doron Betel, Evelyn Yao, Massimo Squatrito, Paul Ogrodowski, Elisa de Stanchina, Aleco D'Andrea, Chris Sander, Andrea Ventura. Genes Dev 2009
375
25

miR-21 expression predicts prognosis in diffuse large B-cell lymphoma.
Jing Li, Rong Fu, Liping Yang, Weiping Tu. Int J Clin Exp Pathol 2015
36
25

Targeting oncogenic Myc as a strategy for cancer treatment.
Hui Chen, Hudan Liu, Guoliang Qing. Signal Transduct Target Ther 2018
362
25

MicroRNAs as regulators and mediators of c-MYC function.
Rene Jackstadt, Heiko Hermeking. Biochim Biophys Acta 2015
85
25

The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas.
Lorena Di Lisio, Nerea Martinez, Santiago Montes-Moreno, Miguel Piris-Villaespesa, Margarita Sanchez-Beato, Miguel A Piris. Blood 2012
55
25

Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma.
Jia Song, Qing Shao, Chunhong Li, Hui Liu, Jing Li, Yihao Wang, Wenjing Song, Lijuan Li, Guojin Wang, Zonghong Shao,[...]. Medicine (Baltimore) 2017
26
25

Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response.
Mahnaz Sahraei, Balkrishna Chaube, Yuting Liu, Jonathan Sun, Alanna Kaplan, Nathan L Price, Wen Ding, Stanley Oyaghire, Rolando García-Milian, Sameet Mehta,[...]. J Clin Invest 2019
69
25

The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics.
Diana Bautista-Sánchez, Cristian Arriaga-Canon, Abraham Pedroza-Torres, Inti Alberto De La Rosa-Velázquez, Rodrigo González-Barrios, Laura Contreras-Espinosa, Rogelio Montiel-Manríquez, Clementina Castro-Hernández, Verónica Fragoso-Ontiveros, Rosa María Álvarez-Gómez,[...]. Mol Ther Nucleic Acids 2020
121
25

Vitamin D receptor as a master regulator of the c-MYC/MXD1 network.
Reyhaneh Salehi-Tabar, Loan Nguyen-Yamamoto, Luz E Tavera-Mendoza, Thomas Quail, Vassil Dimitrov, Beum-Soo An, Leon Glass, David Goltzman, John H White. Proc Natl Acad Sci U S A 2012
82
25

MAX and MYC: a heritable breakup.
Alberto Cascón, Mercedes Robledo. Cancer Res 2012
120
25

Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair.
Ana-Alicia López-Iglesias, Ana B Herrero, Marta Chesi, Laura San-Segundo, Lorena González-Méndez, Susana Hernández-García, Irena Misiewicz-Krzeminska, Dalia Quwaider, Montserrat Martín-Sánchez, Daniel Primo,[...]. J Hematol Oncol 2017
20
25

MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen.
Haitao Bai, Ju Wei, Chong Deng, Xiaoyu Yang, Chun Wang, Rang Xu. Int J Hematol 2013
54
25

BLIMP-1 and STAT3 counterregulate microRNA-21 during plasma cell differentiation.
Nicholas A Barnes, Sophie Stephenson, Mario Cocco, Reuben M Tooze, Gina M Doody. J Immunol 2012
41
25

C-myc/miR-150/EPG5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer.
Hui Li, Juan Liu, Wenjie Cao, Xiaojuan Xiao, Long Liang, Feng Liu-Smith, Weiwei Wang, Hong Liu, Peng Zhou, Ruoyun Ouyang,[...]. Theranostics 2019
28
25

MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases.
Si Li, Zhu Liang, Liu Xu, Fangdong Zou. Mol Cell Biochem 2012
61
25

B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice.
Sukhinder K Sandhu, Matteo Fassan, Stefano Volinia, Francesca Lovat, Veronica Balatti, Yuri Pekarsky, Carlo M Croce. Proc Natl Acad Sci U S A 2013
62
25

Target gene-independent functions of MYC oncoproteins.
Apoorva Baluapuri, Elmar Wolf, Martin Eilers. Nat Rev Mol Cell Biol 2020
96
25

Strategies to Inhibit Myc and Their Clinical Applicability.
Jonathan R Whitfield, Marie-Eve Beaulieu, Laura Soucek. Front Cell Dev Biol 2017
181
25

Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4.
Anja Hilliard, Brendan Hilliard, Shi-Jun Zheng, Honghong Sun, Takashi Miwa, Wenchao Song, Rüdiger Göke, Youhai H Chen. J Immunol 2006
132
25



Revised response criteria for malignant lymphoma.
Bruce D Cheson, Beate Pfistner, Malik E Juweid, Randy D Gascoyne, Lena Specht, Sandra J Horning, Bertrand Coiffier, Richard I Fisher, Anton Hagenbeek, Emanuele Zucca,[...]. J Clin Oncol 2007
25


Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer.
Taro Koba, Seigo Minami, Yu Nishijima-Futami, Kentaro Masuhiro, Hiromi Kimura, Shinji Futami, Moto Yaga, Masahide Mori, Hiroyuki Kagawa, Takeshi Uenami,[...]. Cancer Chemother Pharmacol 2018
2
50

Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy.
Wyndham H Wilson, Michael L Grossbard, Stefania Pittaluga, Diane Cole, Deborah Pearson, Nicole Drbohlav, Seth M Steinberg, Richard F Little, John Janik, Martin Gutierrez,[...]. Blood 2002
236
25

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Bertrand Coiffier, Eric Lepage, Josette Briere, Raoul Herbrecht, Hervé Tilly, Reda Bouabdallah, Pierre Morel, Eric Van Den Neste, Gilles Salles, Philippe Gaulard,[...]. N Engl J Med 2002
25

Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers.
Wyndham H Wilson, Kieron Dunleavy, Stefania Pittaluga, Upendra Hegde, Nicole Grant, Seth M Steinberg, Mark Raffeld, Martin Gutierrez, Bruce A Chabner, Louis Staudt,[...]. J Clin Oncol 2008
229
25

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
Daniel J Landsburg, Marissa K Falkiewicz, Joseph Maly, Kristie A Blum, Christina Howlett, Tatyana Feldman, Anthony R Mato, Brian T Hill, Shaoying Li, L Jeffrey Medeiros,[...]. J Clin Oncol 2017
95
25

R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma.
Stephan Kreher, Felicitas Lammer, Dieter Augustin, Antonio Pezzutto, Claudia D Baldus. Eur J Haematol 2014
9
25


Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.
Andreas Rosenwald, Susanne Bens, Ranjana Advani, Sharon Barrans, Christiane Copie-Bergman, Mad-Helenie Elsensohn, Yaso Natkunam, Maria Calaminici, Birgitta Sander, Maryse Baia,[...]. J Clin Oncol 2019
94
25

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy.
Kerry J Savage, Nathalie A Johnson, Susana Ben-Neriah, Joseph M Connors, Laurie H Sehn, Pedro Farinha, Douglas E Horsman, Randy D Gascoyne. Blood 2009
463
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.